Anti‐citrullinated peptide antibody: death of the rheumatoid factor?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti‐citrullinated peptide antibody: death of the rheumatoid factor?

Published:2009-06 Issue:12 Volume:190 Page:693-695
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Chatfield Simon M¹,Wicks Ian P¹²,Sturgess Allan D³,Roberts Lynden J⁴

Affiliation:

1. Rheumatology Unit, Royal Melbourne Hospital, Melbourne, VIC.

2. Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC.

3. Rheumatology Unit, St George Hospital, Sydney, NSW.

4. Departments of Internal Medicine and Rheumatology, Townsville Hospital, Townsville, QLD.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2009.tb02640.x

Reference11 articles.

1. Early combination disease modifying antirheumatic drug treatment for rheumatoid arthritis

2. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

3. Studies of the incidence and significance of anti-gamma globulin factors in the aging

4. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fallvorstellung: Polyarthralgien;Sonographie in der Rheumatologie – 50 Fälle;2023

2. Impact of Posttranslational Modification in Pathogenesis of Rheumatoid Arthritis: Focusing on Citrullination, Carbamylation, and Acetylation;International Journal of Molecular Sciences;2021-09-30

3. The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients;Therapeutic Advances in Musculoskeletal Disease;2021-01

4. An overview of autoantibodies in rheumatoid arthritis;Journal of Autoimmunity;2020-06

5. Rheumatoid factor testing in Spanish primary care: A population-based cohort study including 4.8 million subjects and almost half a million measurements;Reumatología Clínica;2019-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3